Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 1.800
-0.030 (-1.64%)
Sep 11, 2026, 4:08 PM HKT
Luye Pharma Group Revenue
Luye Pharma Group had revenue of 3.00B CNY in the half year ending June 30, 2026, a decrease of -2.36%. This brings the company's revenue in the last twelve months to 6.13B, down -0.63% year-over-year. In the year 2025, Luye Pharma Group had annual revenue of 6.31B with 4.07% growth.
Revenue (ttm)
6.13B CNY
Revenue Growth
-0.63%
P/S Ratio
1.03
Revenue / Employee
1.17M CNY
Employees
5,221
Market Cap
7.31B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.31B | 246.93M | 4.07% |
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsLuye Pharma Group News
- 12 days ago - Luye Pharma Group Earnings release: H1 2026 - Filings
- 5 months ago - Luye Pharma Group Earnings release: H2 2025 - Filings
- 5 months ago - Luye Pharma Group Annual report: H2 2025 - Filings
- 1 year ago - Luye Pharma upgraded to Neutral from Sell at Goldman Sachs - TheFly